SBI Securities’s Valion Bio VBIO Stock Holding History

SBI Securities’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8	Hold	16	–	–	﹤0.01%	3941
2026 Q1	$14	Hold	16	–	–	﹤0.01%	3815
2025 Q4	$23	Hold	16	–	–	﹤0.01%	3756
2025 Q3	$46	Hold	16	–	–	﹤0.01%	3745
2025 Q2	$66	Hold	16	–	–	﹤0.01%	3657
2025 Q1	$41	Sell	16 -2	-11%	-$10	﹤0.01%	3699
2024 Q4	$106	Buy	+18	New	+$84	﹤0.01%	3437

Other funds holding VBIO

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SBI Securities's VBIO Position: Q2 2026 in Review

SBI Securities held its Valion Bio (VBIO) position steady in Q2 2026 at 16 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #3941.

SBI Securities first reported a position in VBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $106 in Q4 2024. 2 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

SBI Securities held 16 shares of Valion Bio worth $8 as of Q2 2026.
SBI Securities left its Valion Bio share count unchanged in Q2 2026.
Valion Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3941 holding.
SBI Securities first reported a position in Valion Bio in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Valion Bio position peaked at $106 in Q4 2024.
2 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.